PATENT CLAIM ANALYSIS

Application Number: 15987974
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["544", "279000"]

Abstract:
The present invention provides a compound of Formula I: wherein R is H, a methyl group, an ethyl group, a n-propyl group, an iso-propyl group, or a n-butyl group; and R 1  is H, a 4′-methyl group, a 4′-OH, a 4′-OMe group, a 2′,3′-C 2 H 4  group, a 3′,4′-C 2 H 4  group, a 3′,4′-diF, a 3′,4′,5′-triF, or a 4′-OCF 3 ; and optionally including a salt or a hydrate of said compound, and further provides a pharmaceutical composition comprising the compound of Formula I and one or more acceptable pharmaceutical carriers. A method of treating a patient having cancer comprising administering a therapeutically effective amount of a compound of Formula I, or a pharmaceutical composition comprising a compound of Formula I and one or more acceptable pharmaceutical carriers to the patient is disclosed.

Claim (Index 6):
The compound of  claim 5  wherein R 1  is H and X is CH2.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 93.0
- Lexical Diversity: 2.40625
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15239080', '15130219', '15479938', '14820646', '14820725']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8241746637653531
- 35 USC 102 Novelty (BERT): 0.5369305344643703
- Combined Prediction Score: 0.7954502508352549
- Mean Citation Score: 380.89424
- Max Citation Score: 483.50107
- Similarity Product: 200.1683068233109

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test